logo
Plus   Neg
Share
Email

Dr. Reddy's To Sell Migraine Drugs Tosymra, Zembrace To Upsher-Smith Labs

Dr. Reddy's Laboratories Ltd. (RDY,DRREDDY) announced Friday that it has entered into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLC.

The company would sell its US and select territory rights for ZEMBRACE SYMTOUCH (sumatriptan injection) 3 mg and TOSYMRA (sumatriptan nasal spray) 10 mg, formerly referred to as "DFN-02". These are commercialized through the company's unit Promius Pharma, LLC.

Under the deal, Dr. Reddy's will receive $70 million as upfront consideration, $40.5 million in near term milestones, as well as additional financial considerations including existing contractual obligation and inventory.

Subsequently, Dr. Reddy's will receive sales based royalties on a quarterly basis.

The closing of the sale is subject to various customary closing conditions including antitrust review under Hart-Scott-Rodino Act.

Anil Namboodiripad, Senior Vice President, Proprietary Products and Head, Promius Pharma, said, "Tosymra and Zembrace were designed and developed with the goal of addressing unmet needs of large but discrete segments of patients suffering from episodic migraine who need options other than their current therapies."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Libra Association, formed by major financial partners of Facebook's Libra cryptocurrency project, formalized the association at the inaugural Libra Council meeting of the members at its headquarters in Geneva, Switzerland. The current 21 member organizations formally signed onto the Libra Association charter, elected the Board of Directors, and appointed the executive team. Department store chain Kohl's Corp. has unveiled its Kohl's Cares holiday collection that includes the Disney Frozen 2 and Holiday Character bundles. The company's philanthropic program, Kohl's Cares, sells children's books as well as toys and donates the entire profit to charitable initiatives nationwide. Children's Place Inc. (PLCE) said that it will relaunch the Gymboree brand in the U.S. and Canada in early 2020. The brand will be relaunched in Gymboree website, and in shop-in-shop locations in more than 200 Children's Place stores in the U.S. and Canada.
RELATED NEWS
Follow RTT
>